<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Evry_Notebook_w10"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Evry/Notebook/w10">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Evry/Notebook/w10&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Evry/Notebook/w10&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Evry/Notebook/w10&amp;action=history">History               </A></LI><LI style="color:white;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Evry/Notebook/w10" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Evry/Notebook/w10</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2013.igem.org</H3><P><TITLE>Iron coli project</TITLE></P><DIV id="header"><UL id="menu"><LI><A id="home-link" href="https://2013.igem.org/Team:Evry">Home</A></LI><LI><A id="project-link" href="https://2013.igem.org/Team:Evry/Project" title="Overview">Project</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_metabolism">Iron metabolism</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_diseases">Related diseases</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Project_FUR">Iron chelators</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Achievements">Achievements</A></LI><LI><A href="https://2013.igem.org/Team:Evry/References">References</A></LI></UL><LI><A id="team-link" href="https://2013.igem.org/Team:Evry/Team" title="Our team">Team</A></LI><LI><A href="https://igem.org/Team.cgi?id=1163" target="_blank">iGEM Profile</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Attributions">Attributions</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Collaborations">Collaborations</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Acknowledgement">Acknowledgement</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Press">Press</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Gallery">Photo gallery</A></LI><LI><A id="model-link" href="https://2013.igem.org/Team:Evry/Modeling" title="Overview">Model</A></LI><LI><A href="https://2013.igem.org/Team:Evry/flush_model">Flush treatment</A></LI><LI><A href="https://2013.igem.org/Team:Evry/ent_prod">Enterobactin production</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Metabolism_model">Genome scale</A></LI><LI><A href="https://2013.igem.org/Team:Evry/pop_scale">Population scale</A></LI><LI><A href="https://2013.igem.org/Team:Evry/LogisticFunctions">Logistic functions</A></LI><LI><A href="https://2013.igem.org/Team:Evry/ChemicalTools">Chemical reasoning</A></LI><LI><A href="https://2013.igem.org/Team:Evry/data_analysis">Plate Reader</A></LI><LI><A id="biology-link" href="https://2013.igem.org/Team:Evry/Biology" title="Overview">Biology</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Parts">Parts</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Sensor">Sensor</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Inverter">Inverter</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Chelator">Chelator</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Results">Results</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice" title="Overview">Human Practice</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Expert_consultation">Consultation</A></LI><LI><A href="https://2013.igem.org/Team:Evry/HumanPractice/Patients_perceptions">Survey</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Seminar">Seminar</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Philosophy">Philosophy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Safety">Safety</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Economy">Economy</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Art">Art</A></LI><LI><A id="ref-link" href="https://2013.igem.org/Team:Evry/Pill_design">Capsule</A></LI><LI><A id="notebook-link" href="https://2013.igem.org/Team:Evry/Notebook" title="Notebook">Notebook</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols">Protocols</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Primers">Primers</A></LI><LI><A id="spon-link" href="https://2013.igem.org/Team:Evry/Sponsors">Sponsors</A></LI></DIV><DIV class="onglet-left"><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Protocols#Protocol's_overview">Protocols: BioBricks' Conception</A></LI><DIV class="hide"><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Protocol's_overview" title="Protocol's overview">Protocols' overview</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Media" title="Solutions and Media">Solutions and Media</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#DNA_genomic_extraction" title="DNA genomic extraction">DNA genomic extraction</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Polymerase_Chain_Reaction" title="PCR">PCR</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Golden_Gate" title="Golden Gate">Golden Gate</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Competent_cells" title="Competent cells">Competent cells</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Transformation" title="Transformation">Transformation</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Plasmid_purification" title="Plasmid purification ">Plasmid purification </A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Electrophoresis" title="Ectrophoresis">Ectrophoresis</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#PCR_Purification" title="PCR Purification ">PCR Purification </A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#BioBrick_Assembly" title="BioBrick Assembly ">BioBrick Assembly </A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Protocols#Characterization_overview">Protocols: BioBricks' Characterization</A></LI><DIV class="hide"><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Characterization_overview" title="Protocols' overview">Protocols' overview</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#TECAN_Analysis" title="TECAN Analysis">TECAN Analysis</A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Microfluidic_experiment " title="Microfluidic experiment ">Microfluidic experiment </A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Homologous_recombination " title="Homologous recombination ">Homologous recombination </A></LI><LI><A href="https://2013.igem.org/Team:Evry/Protocols#Siderophore_detection " title="Siderophore detection ">Siderophore detection </A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Primers">Primers</A></LI></UL></DIV><DIV class="onglet"><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Notebook/#week1">JUNE</A></LI><DIV class="hide"><LI id="w1"><A href="https://2013.igem.org/Team:Evry/Notebook#week1" title="17th June - 23rd June">Week 1</A></LI><LI id="w2"><A href="https://2013.igem.org/Team:Evry/Notebook#week2" title="24th June - 30th June">Week 2</A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Notebook/#week3">JULY</A></LI><DIV class="hide"><LI id="w3"><A href="https://2013.igem.org/Team:Evry/Notebook#week3" title="1st July - 7th July">Week 3</A></LI><LI id="w4"><A href="https://2013.igem.org/Team:Evry/Notebook#week4" title="8th July - 14th July">Week 4</A></LI><LI id="w5"><A href="https://2013.igem.org/Team:Evry/Notebook#week5" title="15th July - 21st July">Week 5</A></LI><LI id="w6"><A href="https://2013.igem.org/Team:Evry/Notebook#week6" title="22nd July - 28th July">Week 6</A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Notebook#/week7">AUGUST</A></LI><DIV class="hide"><LI id="w7"><A href="https://2013.igem.org/Team:Evry/Notebook#week7" title="29th July - 4th August">Week 7</A></LI><LI id="w8"><A href="https://2013.igem.org/Team:Evry/Notebook#week8" title="5th August - 11th August">Week 8</A></LI><LI id="w9"><A href="https://2013.igem.org/Team:Evry/Notebook#week9" title="12th August - 18th August">Week 9</A></LI><LI id="w10"><A href="https://2013.igem.org/Team:Evry/Notebook#week10" title="19th August - 25th August">Week 10</A></LI><LI id="w11"><A href="https://2013.igem.org/Team:Evry/Notebook#week11" title="26th August - 1st September">Week 11</A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Notebook/#week12">SEPTEMBER</A></LI><DIV class="hide"><LI id="w12"><A href="https://2013.igem.org/Team:Evry/Notebook#week12" title="2nd September - 8th September">Week 12</A></LI><LI id="w13"><A href="https://2013.igem.org/Team:Evry/Notebook#week13" title="9th September - 15th September">Week 13</A></LI><LI id="w14"><A href="https://2013.igem.org/Team:Evry/Notebook#week14" title="16th September - 22nd September">Week 14</A></LI><LI id="w15"><A href="https://2013.igem.org/Team:Evry/Notebook#week15" title="23rd September - 29th September">Week 15</A></LI></DIV></UL><UL><LI class="vis"><A href="https://2013.igem.org/Team:Evry/Notebook/#week16">OCTOBER</A></LI><DIV class="hide"><LI id="w16"><A href="https://2013.igem.org/Team:Evry/Notebook#week16" title="30th September - 6th October">Week 16</A></LI><LI id="w17"><A href="https://2013.igem.org/Team:Evry/Notebook#week17" title="7th October - 13th October">Week 17</A></LI><LI id="w18"><A href="https://2013.igem.org/Team:Evry/Notebook#week18" title="14th October - 20th October">Week 18</A></LI><LI id="w19"><A href="https://2013.igem.org/Team:Evry/Notebook#week19" title="21st October - 27th October">Week 19</A></LI><LI id="w20"><A href="https://2013.igem.org/Team:Evry/Notebook#week20" title="28th October - 3rd November">Week 20</A></LI></DIV></UL></DIV><DIV id="maincontainer_evry2013notebook"><DIV id="mainTextcontainer"><H1>Week 10: 19<SUP>th</SUP> August - 25<SUP>th</SUP> August</H1><H2>2<SUP>nd</SUP> Construction</H2><H3>Primer hybridation</H3><P>
After sequencing analysis we observed that our Golden Gate results were not significant for the 2<SUP>nd</SUP> construction.
However, our sequences of natural promoter give us good results. Then we supposed that the problem of our Golden Gate come from the hybridation of our synthetic promoters.
We made new hybridations of:
</P><UL><LI>Fur Binding Site 1 to 15 (5 µM)
</LI><LI>Andersen promoter J23100 (5 µM)
</LI><LI>RBS 0034 (5 µM)
</LI></UL><H3>Golden Gate</H3><P>
A new Golden Gate of our 2<SUP>nd</SUP> construction are made with:
</P><UL><LI>Fur Binding Site 1, 2 or 3 + sfGFP
</LI><LI>Fur Binding Site 1, 2 or 3 + LacI-LVA
</LI></UL><P>
5 µL of each Golden Gate product are transformed into Top10 competent cells. To controlled the quality of the transformation, a negative controle (transformation procedure without plasmid) and a positive controle (transformation procedure with plasmid 1A3) are made.
</P><H3>Sequencing preparation</H3><P>
Preculture with LB medium (with carbenicillin) have been launched for Top10 transformed with our 2<SUP>nd</SUP> construction, then minipreps have been realized using the miniprep kit from Machrey Nagel.
</P><TABLE cellpadding="10" cellspacing="0" align="center" border="1"><THEAD><TR><TH align="center">
    Name
   </TH><TH align="center">
    Clone
   </TH><TH align="center">
    Concentration
   </TH><TH align="center">
    260/280
   </TH><TH align="center">
    260/230
   </TH><TH align="center">
    Sequencing
   </TH></TR></THEAD><TBODY><TR><TD align="center"><P>Fur Binding Site n°1
    (with sfGFP)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    20.2 ng/µL
   </TD><TD align="center">
    2.07
   </TD><TD align="center">
    1.29
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD rowspan="4" align="center"><P>Fur Binding Site n°1
    (with LacI-LVA)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    28.5 ng/µL
   </TD><TD align="center">
    2.06
   </TD><TD align="center">
    1.65
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    2
   </TD><TD align="center">
    25.5 ng/µL
   </TD><TD align="center">
    2.01
   </TD><TD align="center">
    1.84
   </TD><TD align="center">
    No sequencing
   </TD></TR><TR><TD align="center">
    3
   </TD><TD align="center">
    45.6 ng/µL
   </TD><TD align="center">
    1.91
   </TD><TD align="center">
    1.90
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    54.7 ng/µL
   </TD><TD align="center">
    1.83
   </TD><TD align="center">
    1.27
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD rowspan="4" align="center"><P>Fur Binding Site n°2
    (with sfGFP)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    29.4 ng/µL
   </TD><TD align="center">
    2.01
   </TD><TD align="center">
    1.46
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    2
   </TD><TD align="center">
    25.5 ng/µL
   </TD><TD align="center">
    2.07
   </TD><TD align="center">
    2.00
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    3
   </TD><TD align="center">
    15.0 ng/µL
   </TD><TD align="center">
    2.21
   </TD><TD align="center">
    1.72
   </TD><TD align="center">
    No sequencing
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    47.1 ng/µL
   </TD><TD align="center">
    1.84
   </TD><TD align="center">
    1.53
   </TD><TD align="center">
    -
   </TD></TR><TR><TD rowspan="4" align="center"><P>Fur Binding Site n°2
    (with LacI-LVA)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    25.4 ng/µL
   </TD><TD align="center">
    1.72
   </TD><TD align="center">
    0.60
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    2
   </TD><TD align="center">
    27.7 ng/µL
   </TD><TD align="center">
    1.93
   </TD><TD align="center">
    1.67
   </TD><TD align="center">
    No sequencing
   </TD></TR><TR><TD align="center">
    3
   </TD><TD align="center">
    41.8 ng/µL
   </TD><TD align="center">
    1.87
   </TD><TD align="center">
    1.69
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    31.1 ng/µL
   </TD><TD align="center">
    1.82
   </TD><TD align="center">
    1.26
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD rowspan="4" align="center"><P>Fur Binding Site n°3
    (with sfGFP)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    37.8 ng/µL
   </TD><TD align="center">
    1.85
   </TD><TD align="center">
    1.40
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    2
   </TD><TD align="center">
    78.3 ng/µL
   </TD><TD align="center">
    1.87
   </TD><TD align="center">
    1.85
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    3
   </TD><TD align="center">
    53.4 ng/µL
   </TD><TD align="center">
    1.72
   </TD><TD align="center">
    0.98
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center"> 23.3 ng/µL
   </TD><TD align="center">
    2.06
   </TD><TD align="center">
    2.53
   </TD><TD align="center">
    No sequencing
   </TD></TR><TR><TD rowspan="2" align="center"><P>Fur Binding Site n°3
    (with LacI-LVA)</P></TD><TD align="center">
    2
   </TD><TD align="center">
    43.8 ng/µL
   </TD><TD align="center">
    1.78
   </TD><TD align="center">
    1.21
   </TD><TD align="center">
    Bad
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    28.2 ng/µL
   </TD><TD align="center">
    2.15
   </TD><TD align="center">
    2.31
   </TD><TD align="center">
    -
   </TD></TR></TBODY></TABLE><H2>3<SUP>rd</SUP> construction</H2><H3>Sequencing preparation</H3><P>
Preculture with LB medium (with carbenicillin) have been launched for Top10 transformed with our plasmid which contains the sfGFP under the control of Lac O promoter. After one night of culture minipreps of 3 different clones have been realized using the miniprep kit from Machrey Nagel.
</P><TABLE cellpadding="10" cellspacing="0" align="center" border="1"><THEAD><TR><TH align="center">
    Name
   </TH><TH align="center">
    Clone
   </TH><TH align="center">
    Concentration
   </TH><TH align="center">
    260/280
   </TH><TH align="center">
    260/230
   </TH><TH align="center">
    Sequencing
   </TH></TR></THEAD><TBODY><TR><TD rowspan="4" align="center"><P>Enterobactin construction
    (Lac O with EntA, EntD, EntF)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    62.7 ng/µL
   </TD><TD align="center">
    2.02
   </TD><TD align="center">
    0.84
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    2
   </TD><TD align="center">
    86.8 ng/µL
   </TD><TD align="center">
    1.97
   </TD><TD align="center">
    0.99
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    3
   </TD><TD align="center">
    112.2 ng/µL
   </TD><TD align="center">
    1.98
   </TD><TD align="center">
    1.23
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    78.7 ng/µL
   </TD><TD align="center">
    1.97
   </TD><TD align="center">
    1.17
   </TD><TD align="center">
    -
   </TD></TR><TR><TD rowspan="2" align="center"><P>Enterobactin construction
    (Lac O with EntB, EntC, EntE)</P></TD><TD align="center">
    1
   </TD><TD align="center">
    80.1 ng/µL
   </TD><TD align="center">
    1.92
   </TD><TD align="center">
    1.01
   </TD><TD align="center">
    -
   </TD></TR><TR><TD align="center">
    4
   </TD><TD align="center">
    330.3 ng/µL
   </TD><TD align="center">
    1.91
   </TD><TD align="center">
    1.20
   </TD><TD align="center">
    -
   </TD></TR></TBODY></TABLE><H2>Other</H2><P>
We prepared 20 tubes of BL21 competent cells.
</P></DIV></DIV><DIV id="footer-wrapper"><DIV id="footer"><DIV>Contact: <A href="mailto:igemevry@gmail.com">igemevry@gmail.com</A></DIV></DIV><DIV align="center" style="font-size:60%">Site developped by Gabriel Guillocheau</DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2013.igem.org/Team:Evry/Notebook/w10">http://2013.igem.org/Team:Evry/Notebook/w10</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Evry/Notebook/w10" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Evry/Notebook/w10" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Evry/Notebook/w10&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Evry/Notebook/w10&amp;oldid=89729" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2013.igem.org:Privacy_policy" title="2013.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2013.igem.org:General_disclaimer" title="2013.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>